Regenxbio RGNX SEC Filings

NASDAQ RGNX
$8.95 -0.25 (-2.72%)
As of: Sep 4, 2026 · 1:28 PM EDT
EDGAR Disclosures

Regulatory Filings

Source SEC EDGAR

Every regulatory document REGENXBIO Inc. (RGNX) has filed with the SEC, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

# Form Type Form Group Accession Date Filing Index